Table of Contents

e-Letters

• Observations

  • Open Access

    Dry Eye Syndrome in Subjects With Diabetes and Association With Neuropathy

    Vasilis Achtsidis, Ioanna Eleftheriadou, Eleftheria Kozanidou, Konstantine I. Voumvourakis, Eleftherios Stamboulis, Panos G. Theodosiadis and Nicholas Tentolouris

    Diabetes Care 2014 Oct; 37 (10): e210-e211. https://doi.org/10.2337/dc14-0860
  • Open Access

    Glycemic Control in Diabetic Patients With Impaired Endogenous Insulin Secretory Capacity Is Vulnerable After a Natural Disaster: Study of Great East Japan Earthquake

    Mamiko Tanaka, Junta Imai, Michihiro Satoh, Takanao Hashimoto, Tomohito Izumi, Shojiro Sawada, Kenji Uno, Yutaka Hasegawa, Keizo Kaneko, Tetsuya Yamada, Yasushi Ishigaki, Yutaka Imai and Hideki Katagiri

    Diabetes Care 2014 Oct; 37 (10): e212-e213. https://doi.org/10.2337/dc14-1479
  • Open Access

    Latent Autoimmune Diabetes in Stiff-Person Syndrome

    Spiros Fourlanos, Andrew Neal, Michelle So and Andrew Evans

    Diabetes Care 2014 Oct; 37 (10): e214-e215. https://doi.org/10.2337/dc14-1444

• Comments and Responses

  • Open Access

    Comment on Bordeleau et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366

    Samy Suissa and Laurent Azoulay

    Diabetes Care 2014 Oct; 37 (10): e216. https://doi.org/10.2337/dc14-1075
  • Open Access

    Response to Suissa and Azoulay. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366

    Louise Bordeleau and Hertzel C. Gerstein

    Diabetes Care 2014 Oct; 37 (10): e217. https://doi.org/10.2337/dc14-1220
  • Open Access

    Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670

    Ajay Chaudhuri, Nitesh Kuhadiya, Husam Ghanim and Paresh Dandona

    Diabetes Care 2014 Oct; 37 (10): e218. https://doi.org/10.2337/dc14-1052
  • Open Access

    Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670

    Gayatri Sarkar, May Alattar, Rebecca J. Brown, Michael J. Quon, David M. Harlan and Kristina I. Rother

    Diabetes Care 2014 Oct; 37 (10): e219-e220. https://doi.org/10.2337/dc14-1482
  • Open Access

    Comment on Bordeleau et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366

    Marjolein M.J. Zanders, Andrew G. Renehan, Samantha L. Bowker, Bendix Carstensen, Lonneke V. van de Poll-Franse and Jeffrey A. Johnson

    Diabetes Care 2014 Oct; 37 (10): e221-e222. https://doi.org/10.2337/dc14-1380
  • Open Access

    Response to Zanders et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366

    Louise Bordeleau and Hertzel C. Gerstein

    Diabetes Care 2014 Oct; 37 (10): e223. https://doi.org/10.2337/dc14-1567
  • Open Access

    Comment on Kramer et al. Glucagon Response to Oral Glucose Challenge in Type 1 Diabetes: Lack of Impact of Euglycemia. Diabetes Care 2014;37:1076–1082

    Nobuyuki Takahashi, Tetsuro Tsujimoto and Hiroshi Kajio

    Diabetes Care 2014 Oct; 37 (10): e224. https://doi.org/10.2337/dc14-1500
  • Open Access

    Response to Comment on Kramer et al. Glucagon Response to Oral Glucose Challenge in Type 1 Diabetes: Lack of Impact of Euglycemia. Diabetes Care 2014;37:1076–1082

    Caroline K. Kramer, Ravi Retnakaran and Bernard Zinman

    Diabetes Care 2014 Oct; 37 (10): e225. https://doi.org/10.2337/dc14-1636
  • Open Access

    Comment on Doyle et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms. Diabetes Care 2014;37:1191–1197

    Nick S. Oliver, Mark L. Evans, Roman Hovorka, Simon Heller, Desmond G. Johnston, Stephanie A. Amiel and Katharine Barnard

    Diabetes Care 2014 Oct; 37 (10): e226-e227. https://doi.org/10.2337/dc14-1499
  • Open Access

    Response to Comment on Doyle et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms. Diabetes Care 2014;37:1191–1197

    Francis J. Doyle III, Lauren M. Huyett, Joon Bok Lee, Howard C. Zisser, David Kerr and Eyal Dassau

    Diabetes Care 2014 Oct; 37 (10): e228. https://doi.org/10.2337/dc14-1693
  • Open Access

    Comment on Grunberger “Insulin Analogs—Are They Worth It? Yes!” Diabetes Care 2014;37:1767–1770 and Davidson “Insulin Analogs—Is There a Compelling Case to Use Them? No!” Diabetes Care 2014;37:1771–1774

    Dario Giugliano, Michela Petrizzo, Maria Ida Maiorino, Giuseppe Bellastella and Katherine Esposito

    Diabetes Care 2014 Oct; 37 (10): e229-e230. https://doi.org/10.2337/dc14-1390
  • Open Access

    Response to Comment on Grunberger “Insulin Analogs—Are They Worth It? Yes!” Diabetes Care 2014;37:1767–1770 and Davidson “Insulin Analogs—Is There a Compelling Case to Use Them? No!” Diabetes Care 2014;37:1771–1774

    Mayer B. Davidson

    Diabetes Care 2014 Oct; 37 (10): e231. https://doi.org/10.2337/dc14-1605
  • Open Access

    Response to Comment on Grunberger “Insulin Analogs—Are They Worth It? Yes!” Diabetes Care 2014;37:1767–1770 and Davidson “Insulin Analogs—Is There a Compelling Case to Use Them? No!” Diabetes Care 2014;37:1771–1774

    George Grunberger

    Diabetes Care 2014 Oct; 37 (10): e232. https://doi.org/10.2337/dc14-1643